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Background: The rapid ageing of the population is becoming an area of great concern, both globally and in
Australia. On a societal level, the cost of supporting an ageing demographic, particularly with their associated
medical requirements, is becoming an ever increasing burden that is only predicted to rise in the foreseeable
future. The progressive decline in individuals’ cognitive ability as they age, particularly with respect to the ever
increasing incidence of Alzheimer’s Disease (AD) and other cognitive complications, is in many respects one of the
foundation stones of these concerns. There have been numerous observational studies reporting on the positive
effects that aerobic exercise and the Mediterranean diet appear to have on improving cognitive ability. However,
the ability of such interventions to improve cognitive ability, or even reduce the rate of cognitive ageing, has not
been fully examined by substantial interventional studies within an ageing population.
Methods: The LIILAC trial will investigate the potential for cognitive change in a cohort of cognitively healthy
individuals, between the ages of 60 and 90 years, living in independent accommodation within Australian aged
care facilities. This four-arm trial will investigate the cognitive changes which may occur as a result of the introduction of
aerobic exercise and/or Mediterranean diet into individuals’ lifestyles, as well as the mechanisms by which these changes
may be occurring. Participants will be tested at baseline and 6 months on a battery of computer based cognitive
assessments, together with cardiovascular and blood biomarker assessments. The cardiovascular measures will
assess changes in arterial stiffness and central pulse pressures, while the blood measures will examine changes in
metabolic profiles, including brain derived neurotrophic factor (BDNF), inflammatory factors and insulin sensitivity.
(Continued on next page)* Correspondence: gikennedy@swin.edu.au
†Equal contributors
1Centre for Human Psychopharmacology, Swinburne University of
Technology, Melbourne, Australia
Full list of author information is available at the end of the article
© 2015 Hardman et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Hardman et al. Nutrition Journal  (2015) 14:53 Page 2 of 10(Continued from previous page)
Conclusion: It is hypothesised that exercise and Mediterranean diet interventions, both individually and in
combination, will result in improvements in cognitive performance compared with controls. Positive findings in
this research will have potential implications for the management of aged care, particularly in respect to reducing
the rate of cognitive decline and the associated impacts both on the individual and the broader community.
Trial registration: Australia New Zealand Clinical Trial Registry-ACTRN12614001133628
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The decline in cognitive ability with increasing age has
been well established [1–4] and is associated with a re-
duction of functioning in areas such as attention regula-
tion, processing speed and memory capacity [5]. This
phenomenon of cognitive decline is of considerable con-
cern on an individual level. In ageing and elderly popula-
tions significant concerns exist regarding the loss of
mental faculties and independence of living, which is a
cause of considerable psychological distress [1].
On a societal level this phenomenon is also of substan-
tial concern, particularly with the current rapid ageing of
the population. The over 60s are the fastest growing age
demographic on Earth [6]. It is predicted, that almost one
third of the total population of the planet will be aged
60 years or older by 2100 [7], with this percentage pre-
dicted to be reached by just 2025 in the Pacific/Oceanic
region [8]. In Australia alone, the combined financial cost
of formal and informal care of those with cognitive im-
pairment and dementia was estimated to be around
AU$8.2 billion in 2010 [9]. This cost is expected to rise to
over AU$28 billion by 2040, causing considerable strain
on the economy. It has also been predicted that a reduc-
tion of just two years in the onset of care requirements
due to these age related cognitive issues could result in a
10 % reduction in the overall financial burden [9]. Given
the societal and personal consequences, understanding
the mechanisms behind the differential rates of cognitive
ageing, and designing strategies to prevent or reduce the
rate of cognitive decline that are simple and cost effective
to implement, are of critical importance.
What is cognitive ageing?
While there are multiple ways to characterise cognitive
ability, it is commonly divided into crystallised intelligence
and fluid intelligence. Crystallised intelligence refers to the
knowledge and skills that are accumulated over a lifetime
[10, 11]. This includes mental functions such as verbal
ability, general knowledge and some numerical abilities
[2]. Fluid intelligence, often highly associated with cog-
nitive speed [12], refers to the ability to process informa-
tion, think abstractly and solve problems. This includes
aspects of memory, executive functioning and reason-
ing, and is considered to be largely innately determined[2, 13]. There is general consensus that while crystallised
intelligence remains intact until late old age, fluid abilities
decline progressively from middle adulthood onwards [14,
15]; and this decline appears to affect a number of fluid
cognitive functions simultaneously. However, while the
average performance on most fluid cognitive tasks have
been found to decline with age, many studies have shown
that some older people display comparatively little change,
whereas others deteriorate quite rapidly [16, 17] and that
this variability increases with increasing age [5].
Earlier research on the relationship between age and
cognitive decline indicates that an individual’s cognitive
performance increases up until adolescence or early adult-
hood and then progressively declines. However, the age at
which decline begins and the extent of decline varies for
different abilities [18]. It is the ageing brain and the conse-
quences of long term effects on the brain that result in
speed and memory performance decline [10, 14]. The age-
ing of the brain may be considered as a progressive and
inevitable process potentially related to inflammation, the
accumulation of oxidative stress and the related damage
to cellular structures of the brain [19]. During normal age-
ing the brain may suffer morphological and functional
deterioration that will potential affect neurotransmission
and the alteration of motor and sensory systems, sleep,
memory and potential learning [19–22].
A comprehensive review of earlier studies concluded
that a slower rate of cognitive ageing could be predicted
to a certain degree (along with other factors such as
more years of education and an absence of the APOE ε4
allele) by an active lifestyle and better cardiovascular
health [10]. This apparent effect of cardiovascular health
on the rate of cognitive decline associated with increas-
ing age has also been found by numerous recent studies
[23–25]. More specifically, along with avoidance of smok-
ing and limited alcohol consumption, optimisation of car-
diovascular health can be most readily achieved through
regular exercise and an anti-inflammatory diet focused on
fruits and vegetables, such as the Mediterranean diet [26].
Cognition and exercise
Numerous studies have identified benefits of exercise train-
ing for the cognitive functioning of older adults [27]. A
meta-analysis, published in 2012, of 29 studies in older
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exercise interventions, ranging from 8 to 72 weeks, im-
proved cognitive faculties including attention, processing
speed, executive function, and memory [28] In a recent
Australian study, older participants engaged in moderate
aerobic exercise for 50 min three times per week for
6 months [29]. At the end of the study period, individuals
in the exercise condition showed enhanced cognition in
comparison to those not engaged in the exercise regime.
The cognitive benefits of exercise appear to increase
with frequency of exercise [30], and are greatest for mod-
erate (31–45 min) duration exercise sessions [27]. Whilst
it has been suggested that the greatest cognitive improve-
ments may occur when aerobic exercise is combined with
strength training [28], there is evidence that walking pro-
grams may also be effective to improve cognitive function
[31]. In a recent study conducted in seniors, half of the
participants took part in a 90 min weekly walking program
and half served as a control group [32]. After 3 months
there was a significant improvement in word fluency, so-
cial interaction and motor function in those who partici-
pated in the walking program.
Several mechanisms of action have been proposed to
account for the cognitive benefits of exercise in older adults.
Long term effects of exercise may have indirect effects upon
neurocognitive functioning by reducing diabetes, hyperten-
sion and cardiovascular disease [33]. Exercise may also have
direct effects on brain physiology. There is increasing
evidence that extended periods of exercise leads to in-
creased volume of the hippocampus, a brain region vital
for memory function, as well as reducing the rate of cere-
bral grey matter shrinkage [34]. Shorter term mechanisms
have also been proposed, due to the identification of
cognitive improvements following exercise interventions
of several months [28]. For example, exercise may protect
against inflammatory processes and regulate growth factor
signalling in the brain [33]. Furthermore it has been
suggested that exercise may interact with BDNF, a
neurochemical which modulates brain plasticity, neuritic
outgrowth, synaptic function, and can stimulate adult hip-
pocampal neurogenesis [34].
Cognition and diet
Dietary factors are considered to have a powerful influ-
ence on brain function on a daily basis [35]. With respect
to the type of diet that may be of long term benefit, it has
been found that people who adhere to a Mediterranean-
style diet could reduce the potential for progression from
healthy cognitive function to mild cognitive impairment
(MCI) and subsequently to dementia [36–39]. Addition-
ally, a diet higher in components of the Mediterranean
diet has been found to correlate positively with reduced
changes in Mini Mental State Examination (MMSE)
scores over five or more years in cognitively healthypeople over the age of 65 [40–42]. The Mediterranean
diet refers to the dietary practices of populations from
the Mediterranean regions. This diet consists predom-
inantly of fruits, vegetables, nuts, cereals, legumes, fish
and olive oil, with a moderate intake of alcohol and lower
consumption of red meat and poultry. Adherence to the
Mediterranean diet has also been linked to lower risk of
mortality and vascular events [43], as well a reduction in
the incidence of MCI [38].
It has also been found that specific nutritional intake
has an impact on overall mental health and function [44].
Antioxidant-rich and flavonol containing components of
the Mediterranean diet have been correlated with better
performance on spatial working memory in younger
women, aged 19 to 30 years, in as little as 10 days [45].
This correlation was also found across multiple measures
of memory in people aged 55 to 80 years [46].
Similar to exercise interventions, it is likely that vascu-
lar processes and inflammatory pathways may also medi-
ate the relationship between the Mediterranean diet and
cognition. An eight week Mediterranean diet interven-
tion has been showed to reduce circulatory markers of
inflammation [47, 48]. This may be due to the combined
effects of a range of components of the Mediterranean
diet. A higher intake of fruit and vegetables has been as-
sociated with higher blood nutrient levels, lower oxidative
stress and better cognitive function [49]. A high consump-
tion of fruit and vegetables, or a diet that is full of antioxi-
dants, carotenoids, vitamins, fibre and magnesium, has
been shown to be beneficial in reducing C-reactive protein
(CRP) levels, a marker of inflammation closely linked
to cognition [50]. In addition, flavonoids found in fruit
and vegetables, and omega-3 polyunsaturated fatty acids
found in high quantities in fish, have demonstrated
anti-inflammatory, cardio-protective and neuro-protective
properties [51, 52].
The cardio-protective nature of the Mediterranean diet
has been investigated through an intervention study in-
volving 342 participants. This study found that on a 10
point Mediterranean diet adherence scale, even a 1 point
increase in adherence to this type of diet resulted in an
18 % reduction in the relative associated risk of a myo-
cardial infarction [53]. It has also been found that the in-
creased consumption of olive oil and whole grains, that
are part of a Mediterranean diet, are both independently
associated with a decrease in systolic and diastolic blood
pressure [54]. Additionally, another major component of
the Mediterranean diet, the increased intake of fish, has
also been found to reduce both blood pressure and blood
lipids [37, 55]. Finally, it been suggested that the Medi-
terranean diet may benefit insulin sensitivity and subse-
quently have a positive effect on decreasing cardiovascular
disease [56]. This is further supported by reviews of Medi-
terranean food patterns and prevention of chronic disease,
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ranean style of diet was associated with a reduction in cor-
onary heart disease [53, 57].
To date, very few studies have conducted randomised
controlled based assessment of the effect of Mediterra-
nean diet on health or cognitive outcomes. Recently a
3-arm control randomised study was undertaken using
a Mediterranean diet pattern and nuts. The results of
this study indicated that the Mediterranean diet has a
protective effect on cardiovascular health and also cog-
nitive function [58]. However, the mechanisms by which
Mediterranean diet may actually achieve the observed
improvements in cognitive performance or improved car-
diovascular health have not yet been fully investigated. In
particular the effect of this diet on the combination of
arterial stiffness, central pulse pressures, circulatory
biomarkers of inflammation and changes in BDNF.
Additionally, while there have been numerous obser-
vational studies, to date no clinical trial of the effects
of a Mediterranean diet, in elderly populations, using
sensitive tests of specific cognitive functions, has been
found.
Cognition and combined exercise and diet
Exercise can potentially overcome the effects of a poor
diet [59] and, in animal trials, exercise has been found to
improve cognitive performance and increase hippocam-
pal BDNF in rats with diet induced cognitive decline
[60]. Conversely, it has been suggested that diet high in
fruit and vegetables, combined with exercise, can assist
the brain to cope with several types of insults and ultim-
ately benefit brain function over time [59].
Healthy diet and exercise are associated with a reduced
risk of cognitive decline and may provide opportunities to
reduce the threat of cognitive decline more effectively
than that which is currently understood [61]. With the in-
creasing understanding of molecular biology it has been
shown that diet and exercise can affect analogous molecu-
lar systems and that this can help lead us to understand a
mechanism by which lifestyle, such as exercise and diet
may positively influence brain plasticity [59]. Additionally,
endothelial dysfunction has been associated with reduced
cognitive performance [62], and, in a recent study of
healthy older people, a combined Mediterranean diet and
exercise intervention was found to provide enduring im-
provement in vascular endothelial function [63].
However, while there is support for the idea that Medi-
terranean diet and exercise will combine synergistically to
reduce the rate of cognitive decline, there are two main
aspects which require further investigation. Firstly, while
there is an acknowledged need for a clinical trial of the ef-
fects of exercise and diet on cognitive function [61, 64],
no such trial has been undertaken as yet. Secondly, the
mechanisms by which Mediterranean diet and exercisemay affect cognition have yet to be fully investigated. The
current study aims to address both of these issues.
Aims and study hypotheses
The primary aim of the current study is to examine the
6-month effects of increased exercise through walking,
change to a Mediterranean diet, and a combination of
both, on cognitive performance in an elderly population
living independently in aged care facilities. It is hypothe-
sised that measures of cognitive performance will be im-
proved in both the exercise and dietary interventions,
relative to the controls, and that the combined diet and
exercise intervention will show the greatest improvement
of all groups.
As a secondary aim, this study will also investigate the
associations between cognitive function and blood based
biomarkers and cardiovascular function, which have been
proposed as mechanisms, or indicators of mechanisms,
that may influence the rate of cognitive ageing. By investi-
gating these variables, the current study aims to identify
and target modifiable risk factors, as well as identifying
objective biological indicators of the efficacy of interven-




This is a randomised, controlled, four-arm parallel groups
design. However, given the nature of the interventions,
this study is not blinded as both investigators and partici-
pants will clearly know what the intervention is, as partici-
pants in the lifestyle arms will be actively working towards
maintaining the lifestyle change. Participants will be ran-




(4)Combined dietary and exercise intervention
The randomisation sequence will be created by permut-
ing into blocks of 4. While allocation of participants to
these groups will be randomised, for reasons of practical-
ity, and to avoid cross contamination between the require-
ments of each group, when cohabiting couples participate,
one person will be randomly allocated to a group and the
other will be allocated to the same group.
Participants
In total, 148 participants who live independently in aged
care facilities across a minimum of 15 sites, and who are
aged between 60 and 90 years, will participate in this
study. These residents live in their own unit or similar
accommodation, and are generally physically and mentally
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ing. The independent aged care resident population was
selected due the generally greater homogeneity of the
population and living conditions than that found in the
broader community. Furthermore, by focusing on inde-
pendent living in aged care facilities, this research aims to
examine the efficacy of programs aimed at minimising
cognitive decline and reducing the rate of transfer to low
and high care accommodation.
Eligibility criteria
To be eligible to participate in the study, participants
must be able to speak and read English fluently. Those
who are not taking vitamins or herbal supplements as
part of a regular regime will be asked to discontinue their
use for the duration of the trial, while those who regularly
take such vitamins or supplements will be asked to con-
tinue taking them in the same manner for the length of
the trial. Finally, participants will be required to get the
approval of their General Practitioner before random allo-
cation and commencement.
Ineligibility criteria
Participants will be unable to participate in the trial if
they have any significant visual impairment that would
prevent them from reading or performing computer
based tasks, have a significant neurological or psychiatric
disorder, or are unable to walk independently and safely.
Additionally, study participants will not be eligible if
taking illicit drugs or cognitive enhancing medications.
Finally, those with suspected cognitive impairment (defined
as a score ≤ 24 on the MMSE), or a significant level of
symptoms of depression (a score > 9 on the Geriatric
Depression Scale (GDS)), will also be excluded.
This study was ethically approved by the Swinburne
University Human Research Ethics Committee (project
number 2013/057) and all participants will provide written
consent from both themselves and their general practi-
tioner before commencement in the trial.
Sample size
To date no studies using specific measures of cognition
more sensitive than the MMSE have investigated the
cognitive effects of a Mediterranean dietary intervention
in the elderly. However, numerous trials have examined
the effects of exercise fitness interventions. In a meta-
analysis conducted to investigate the potential for fitness
training to improve cognition in sedentary, but otherwise
healthy, older adults, fitness training increased cognitive
performance 0.5 SD on average, regardless of the type of
cognitive task or the training method [27]. Using Cohen’s
effect size criteria, this represents a medium effect size
[65]. Although there are no relevant trials which have
focussed on the Mediterranean diet, from which todetermine an effect size, we have previously identified
slightly larger effect sizes on SUCCAB memory measures
following several months combined micronutrient, min-
eral and herbal supplementation in older people with risk
factors for cognitive decline [66, 67]. We would anticipate
the dietary change condition may exert many of the same
benefits as micronutrient dietary supplementation, there-
fore a comparable effect size may be anticipated. Power
analysis was conducted using GPower 3.1.3 to determine
the sample size required for a four armed intervention
(exercise change only, diet change only, exercise and
diet change, no change) using an analysis of variance
(ANOVA) design. It was indicated that a total sample
of 128 participants would be required to detect a moder-
ate effect size (f = 0.30), power of 80 % and a significance
level of 5 %. Based on previous trials conducted by the
Swinburne University Centre for Human Psychopharma-
cology, an allowance for a 15 % drop out from the trial
has been factored in. Therefore, a total sample of 148 par-
ticipants will be recruited for this trial, with 37 individuals
randomised to each arm of the study.
Interventions
Mediterranean diet
Those allocated to one of the diet change groups will be
required to record their estimate of their percentage
adherence to the Mediterranean diet programme each
day, with the goal of reaching and maintaining an 85 %
adherence rate over the duration of the study. This
programme has been produced in association with a
specialist nutritional organisation, and includes a struc-
tured four week programme with meal ideas and recipes.
Additionally, these participants will be supplied with a
standard high-quality extra virgin olive oil to use for the
duration of the trial.
Exercise
While there are a number of types of exercise which are
potentially cognitively beneficial, walking has been se-
lected for this study. Regular walking, in particular, has
been shown to have cognitive benefits in older cohorts
[31, 32]. Additionally, walking does not require supervi-
sion or training from a health professional and may be
suitable for frail elders or those with some functional limi-
tations. For these reasons a walking program is deemed
suitable for older participants and will be practical and
cost effective to implement.
Those allocated to a group which includes exercise will
be required to walk 4 to 5 times a week. They will follow
a graduated program with the aim of walking at least
35–40 min as their aerobic exercise. Any participants
who already walk this amount regularly will be asked to
increase the amount of walking they do. Participants will
be provided with pedometers and will be asked to record
Hardman et al. Nutrition Journal  (2015) 14:53 Page 6 of 10the number of minutes walked, distance travelled and
the number of steps taken for each walking session.
Procedure
Eligible participants will be assessed over four sessions
at their living facility. An overview of these sessions is
provided in the trial flow diagram (Fig. 1). During the
first session, which takes place in the participant’s home,
participants are screened for eligibility and assessed with
the MMSE and the GDS. Eligible participants are requested
to visit their doctor to obtain consent to participate and
then to have blood taken for biomarker analysis. Session 2,
conducted in a central treatment room in that participant’s
living facility, is undertaken once doctor’s consent and
blood biomarkers have been obtained. During this visit
baseline assessment of all measures are undertaken and
participants are informed of the group they have beenFig. 1 LIILAC protocol flow diagramrandomly allocated to. The third session, an in home
visit at the 3 month time point, will collect participant
recorded diet and/or exercise data where appropriate,
and any adherence issues will be discussed. Mood, exer-
cise and sleep questionnaires will also be undertaken at
this session. As shown in Fig. 1, the final session will be
a full assessment visit, assessing all measures. This will
be conducted in a central treatment room of the facility
at the 6 month time point. Participant recorded exercise
and diet data will also be collected during this session,
enabling the investigators to estimate adherence to the
intervention.
Primary outcome
The primary area of interest in this study is the effect of
the dietary and exercise interventions on performance in
a battery of cognitive measures. The Swinburne University
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will be undertaken at baseline and at 6 months post base-
line. The SUCCAB has been used to assess cognitive per-
formance in previous studies [15, 66, 68]. Reliability and
validity assessment has demonstrated that SUCCAB is
sensitive to ageing and correlates strongly with memory
subtests in the WAIS-IV [15]. The primary outcome will
be memory response time calculated as a composite meas-
ure from the SUCCAB memory sub-tests.
Additionally, the MMSE will be used to screen for de-
mentia as well as assessing any global effects of the in-
terventions after 6 months.
Secondary outcomes
Potential mechanisms of action of improvement in cog-
nition through changes in inflammation, glucoregulation,
oxidative stress and more direct brain measures such as
BDNF, will be examined.
The effects on mood, quality of life, cardiovascular func-
tion and overall perceived wellness in these cohorts will
also be investigated as potential mechanisms by which
exercise and dietary change may have an influence on
cognition.
Measures
Every participant in the study will undertake the same
measures, regardless of the intervention they are assigned
to.
Screening
Mini Mental State Examination
Participants will be screened for cognitive impairment
using the MMSE. Scores 24 or lower may indicate cogni-
tive impairment. Participants scoring 24 or lower will not
be eligible for participation.
Geriatric Depression Scale
The 30 item version of the GDS [69] will be used to en-
sure participants are free from depression as late onset
depression can be associated with cognitive impairment.
Participants scoring above 9 will not be eligible for
participation.
Cognitive assessment
Swinburne University Computerised Cognitive Assessment
Battery
The SUCCAB is a validated computer based cognitive
battery consisting of eight measures that were developed,
based on cognitive and neuroimaging literature, to focus
on cognitive domains that were most likely to decline with
increasing age [15]. This battery uses a simple 5 button
interface and has been validated in other studies involving
the elderly [70, 71]. The eight measures of cognitive func-
tioning assessed by the SUCCAB consist of Simple andChoice Reaction Times, Immediate and Delayed Recog-
nition, Congruent and Incongruent Stroop colour-words,
Spatial Working Memory and Contextual Memory. Com-
puterised measures provide consistency in measurement
across participants, and a more automated approach in
analysis. The primary outcome will be a composite
measure comprised of spatial working memory, imme-
diate, delayed and contextual recognition response time.
Secondary outcomes will be response time and accuracy
on the individual SUCCAB measures, with the exception
of the Congruent Stroop and Reaction Time tasks, as ceil-
ing effects for accuracy are anticipated, response times will
be the sole outcome for these tasks.
Cardiovascular assessment
The effect of the intervention on cardiovascular factors
will focus on peripheral and central blood pressures as
well as arterial stiffness. These measures will be conducted
using applanation tonometry with the SphygmoCor XCEL
system. Aortic blood pressure and pulse pressure will be
derived automatically, via a brachial blood pressure cuff.
Standard brachial blood pressure will also be measured
during this process, using an average taken over three
recordings. Pulse wave velocity will be derived using a
femoral cuff to capture the femoral waveform and tonom-
eter pressure sensor to capture the carotid waveform.
Biomarker assessment
The blood tests to be undertaken are: BDNF, Cholesterol,
Triglycerides, Liver Function Test (LFT), Glucose, Urea,
C-Reactive Protein (CRP), Red Cell Folate, Homocysteine,
Haemoglobin A1c (HbA1c), Insulin-Like Growth Factor 1
(IGF-1/Somatomedin C) and Vitamins B6, B12 and D.
Participants will be asked to fast before these blood tests.
Bloods will be taken by a commercial pathology com-
pany or the participant’s medical practitioner. The blood
assessment, with the exception of BDNF, is in accord-
ance with a regular medical assessment and represents
fairly standard 6 month monitoring conducted by the
residents’ medical practitioners.
Mood and wellness assessment
Depression Anxiety Stress Scale (DASS), Profile of Mood
States (POMS) and General Health Questionnaire (GHQ)
These self-report mood scales will be used to assess
changes in mood across the study. The DASS measures
the three related negative emotional states of depression,
anxiety and stress [72]. The POMS used to assess transi-
ent, fluctuating feelings and enduring affect states allow-
ing participants to report their mood over the past week
[73]. The GHQ comprises 60 items and assesses changes
in the ability to carry out normal daily functions, som-
atic symptoms and insomnia, and feelings of anxiety and
depression [74].
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The perceived wellness survey is a set of statements that
are designed to provide information about a person’s well-
ness perceptions [75].
Sleep assessment
This study will include the Pittsburgh Sleep Quality
Index [76]. This measure assesses ‘components’ of sleep
such as disturbances, latency, duration, efficiency, use of
sleep medication and daytime dysfunction.
Dietary assessment
Mediterranean diet scale
Adherence to the Mediterranean diet will be assessed by
a 10-point Mediterranean-diet scale that incorporated the
salient characteristics of this diet. Scores range from 0 to
9, with higher scores indicating greater adherence [77].
Food frequency assessment
The Cancer Council Food Frequency Questionnaire [78]
will be used to collect additional dietary information. They
will also form the basis for nutritional evaluation and to
assess adherence to the Mediterranean Diet.
Exercise assessment
The 6 min walk test
The 6 min Walk test will be utilised to indicate baseline
fitness as well as improvement in fitness over the study
[79]. In this assessment participants will between two
markers placed 10 m apart. The objective of this test is
to walk for as far as possible in 6 min.
Borg assessment
The Modified Borg Scale [80] will be used to rate degree
of breathlessness and/or difficult, uncomfortable or laboured
breathing as well as fatigue level. Participants will complete
the Borg Scale after their 6 min walk test.
Community Healthy Activities Model Program for Seniors
(CHAMPS) questionnaire
The CHAMPS will be used to the assess baseline physical
activity of participants [81]. It will also form part of the as-
sessment of change in overall physical activity across the
duration of the trial.
Demographic and morphometric measures
Age, gender, education and smoking status will be re-
corded at the commencement of the study. Height,
weight, hip and waist circumference will be assessed at
baseline and the six month time point, while medication
and nutritional supplement information will be collected
at all three time points. Additionally, information regard-




The primary outcome will be response time on the SUC-
CAB memory measures. Previously benefits to response
time on SUCCAB memory measures has been demon-
strated following multivitamin [67] and other nutraceut-
ical intervention [68]. Mixed design, repeated measures
analysis of co-variance (ANCOVA) will be used to assess
treatment-related changes in cognitive performance over
the study. Relevant covariates may include group differ-
ences in cognitive performance or biomarkers at baseline
and co-habitation of participants, where couples are tak-
ing part in the intervention trial.
Secondary outcomes
All other cognitive, biomarker, mood, wellness and exer-
cise measures will be treated as secondary outcomes.
Mixed design, repeated measures analysis of covariance
(ANCOVA) will be used to assess treatment-related
changes in all secondary outcomes over the study. Hier-
archical regression will be used to establish the relationship
between change in biomarkers and changes in cognitive
function. Secondary analysis will examine the pooled ef-
fects of the two intervention arms involving the Mediterra-
nean diet versus the control arm and the two intervention
arms involving exercise versus the control arm.
Conclusion
With the rapid ageing of the global population and the
commensurate increase in age related cognitive decline,
there is an exigent need for broadly available and easily
implemented public health interventions that are aimed
at ameliorating this issue. There is support for the effi-
cacy of both the Mediterranean style of diet and aerobic
exercise interventions in positively affecting cognitive
performance in older adults. However, at present, much
of the evidence is observational or not balanced by the
use of control groups. Additionally, there has been little
use of sensitive cognitive measures, covering multiple, spe-
cific cognitive domains. Finally, also lacking in the current
literature is investigation into the possible mechanisms by
which the observed improvements in cognition through
diet and exercise, either individually or in combination,
may be being achieved. The current trial aims to use
clinical trial methodology to test the hypothesis that
both Mediterranean diet and walking based aerobic
exercise, both independently and in combination, will
improve cognitive performance in older people living
independently in aged care facilities. Additionally, through
blood biomarker, cardiovascular and psychological assess-
ments, this study aims to investigate possible mechanisms
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potential to ameliorate the rate of cognitive decline in
older people through achievable lifestyle change may be of
substantial importance to public health in an increasingly
ageing society.
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